The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.

Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...

Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...

Novartis (NVS, Financials) is investing $23 billion over the next five years to expand its manufacturing and research ...